Bank of America’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Bank of America’s Portfolio TSRX Stock Details TSRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-315,632	Closed	-$2.56M	–	8330
2013 Q2	$2.56M	Buy	+315,632	New	+$2.33M	﹤0.01%	2933

Other funds holding TSRX

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Bank of America's TSRX Position: Q3 2013 in Review

Bank of America sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 315,632 shares — an estimated $2.56M sold.

Bank of America first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $2.56M in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

Bank of America reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
Bank of America sold 315,632 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $2.56M.
Bank of America first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
Bank of America's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $2.56M in Q2 2013.
7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on Bank of America's 13F filing for Q3 2013, filed 14 Nov 2013.